Harrow, Inc.
HROW
#5427
Rank
NZ$2.46 B
Marketcap
NZ$66.32
Share price
-0.79%
Change (1 day)
72.32%
Change (1 year)

Earnings for Harrow, Inc. (HROW)

Earnings in 2025 (TTM): NZ$33.49 Million

According to Harrow, Inc.'s latest financial reports the company's current earnings are NZ$0.25 Billion. In 2024 the company made an earning of NZ$9.26 Million, an increase over its 2023 earnings that were of -NZ$4.05 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harrow, Inc. from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$33.49 M261.64%
2024 NZ$9.26 M-329.09%
2023 -NZ$4.05 Million-224.34%
2022 NZ$3.25 M3.01%
2021 NZ$3.15 M149.06%
2020 NZ$1.26 M434.29%
2019 NZ$0.23 M-102.68%
2018 -NZ$8.85 Million-57.11%
2017 -NZ$20.62 Million-21.93%
2016 -NZ$26.4 Million5.11%
2015 -NZ$25.12 Million46.16%
2014 -NZ$17.19 Million32.68%
2013 -NZ$12.96 Million42.63%
2012 -NZ$9.09 Million
2010 -NZ$4.2 Million-45.76%
2009 -NZ$7.74 Million21.83%
2008 -NZ$6.35 Million-491.97%
2007 NZ$1.61 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.28 Billion-902.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$30.77 Million-191.39%๐Ÿ‡บ๐Ÿ‡ธ USA